Media

Pandemic Defense in Action! Can the National Biotechnology Team Avoid “Dropping the Baton”?

Facing a once-in-a-century global pandemic, research institutions and major pharmaceutical companies worldwide have mobilized, advancing R&D on three fronts—“vaccine development,” “new drug treatments,” and “virus testing”—in a race against time to save lives.

New drug development is never easy. Before the final outcome is known, everything remains uncertain. From clinical trials to eventual FDA approval and market launch is an extremely high hurdle. How should one confront the capital-intensive and long journey of new drug development?